Saxagliptin

Details

Files

Generic Name:

Saxagliptin

Project Status:

Withdrawn

Therapeutic Area:

Diabetes mellitus, type 2

Manufacturer:

Bristol-Myers Squibb / AstraZeneca Canada Inc.

Call for patient/clinician input open:

May 28, 2012

Brand Name:

Onglyza

Project Line:

Reimbursement Review

Project Number:

SR0280-000

Call for patient/clinician input closed:

June 18, 2012

Submission Type:

Resubmission

Indications:

Diabetes mellitus (Type 2)

Files

Submission Status Report View PDF

Last Updated : May 28, 2012